wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q31050197-55EC725F-CAB8-48EA-A25B-F72E6A6DC0FF
Q31050197-55EC725F-CAB8-48EA-A25B-F72E6A6DC0FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31050197-55EC725F-CAB8-48EA-A25B-F72E6A6DC0FF
Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials.
P2860
Q31050197-55EC725F-CAB8-48EA-A25B-F72E6A6DC0FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31050197-55EC725F-CAB8-48EA-A25B-F72E6A6DC0FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cd25c54d303df47b273e3a57bb96fc9090dfff8f
P2860
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.